Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1995 1
1996 1
2003 2
2008 3
2012 1
2014 2
2015 1
2016 1
2018 4
2019 4
2020 2
2021 4
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Among authors: foran b. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, Boon C, Cook A, De Winton E, Emson M, Foran B, Frogley R, Petkar I, Pettit L, Rooney K, Roques T, Srinivasan D, Tyler J, Hall E; DARS Trialist Group. Nutting C, et al. Among authors: foran b. Lancet Oncol. 2023 Aug;24(8):868-880. doi: 10.1016/S1470-2045(23)00265-6. Epub 2023 Jul 6. Lancet Oncol. 2023. PMID: 37423227 Free article. Clinical Trial.
Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer.
Hague C, Foran B, Hall E, Guild S, Joseph O, Moule R, Nutting C, Parsons S, Prestwich R, Slevin N, West C, Thomson D. Hague C, et al. Among authors: foran b. Clin Oncol (R Coll Radiol). 2018 May;30(5):274-276. doi: 10.1016/j.clon.2018.01.018. Epub 2018 Feb 17. Clin Oncol (R Coll Radiol). 2018. PMID: 29459100 No abstract available.
Management of the appendiceal mass.
Foran B, Berne TV, Rosoff L. Foran B, et al. Arch Surg. 1978 Oct;113(10):1144-5. doi: 10.1001/archsurg.1978.01370220030005. Arch Surg. 1978. PMID: 708234
TEM Study on Epitaxial BiFeO3 Film under Biaxial Tensile Strain.
Bae IT, Lingley Z, Foran B, Adams P, Paik H. Bae IT, et al. Among authors: foran b. Microsc Microanal. 2023 Jul 22;29(Supplement_1):1684-1685. doi: 10.1093/micmic/ozad067.866. Microsc Microanal. 2023. PMID: 37613795 No abstract available.
Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study.
Vreugdenhil M, Fong C, Iqbal G, Roques T, Evans M, Palaniappan N, Yang H, O'Toole L, Sanghera P, Nutting C, Foran B, Sen M, Al Booz H, Fulton-Lieuw T, Dalby M, Dunn J, Hartley A, Mehanna H. Vreugdenhil M, et al. Among authors: foran b. Clin Oncol (R Coll Radiol). 2021 Dec;33(12):795-803. doi: 10.1016/j.clon.2021.07.009. Epub 2021 Jul 30. Clin Oncol (R Coll Radiol). 2021. PMID: 34340917
28 results